Skip to content
S8633Senate2021-2022 SessionSame asA9697

Free Narcan for Nightlife

Official title

“Relates to establishing the nightlife opioid antagonist program”

Sponsor Leroy ComrieSD-14+4 co-sponsorsAffects Health
Status
Signed by Governor
Impact
7/10
Significant
Outcome
Signed into law

Bill progress

Signed into law

What's happening

This bill creates a program allowing nightlife establishments to obtain free opioid antagonists like naloxone to respond to overdoses.

Why it matters

  1. Expands overdose intervention capacity in high-risk settings. By providing free opioid antagonists to nightlife venues, the bill addresses the reality that overdoses can and do occur in places where alcohol and late-night activity are common, potentially saving lives in environments where medical help may not be immediately available.

  2. Establishes oversight and accountability. The bill requires establishments to report each use, accidental discharge, or expiration of naloxone, and mandates record-keeping and compliance with laws and regulations. This ensures responsible management of the medication and allows the state to track the program’s effectiveness.

  3. Supports public education and safety. Participating establishments will receive resources and training on overdose prevention and opioid antagonist administration, which may raise awareness among staff and patrons about the dangers of opioid use and empower bystanders to act during emergencies.

  4. Limits liability for the state and sets clear participation rules. The legislation explicitly states that the state is not liable for the use or outcomes of opioid antagonist administration by establishments, and creates mechanisms for suspension or reinstatement if venues do not comply with program requirements—helping to maintain safety and integrity.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • Bars, clubs, entertainment venues and restaurants with substantial nighttime business

    Eligible establishments could apply for free opioid antagonists, up to ten doses at a time, subject to reporting, recordkeeping and other participation requirements.

  • Nightlife establishment staff

    The Department of Health would offer participating establishments’ staff resources and training on overdose prevention and administering opioid antagonists.

  • Patrons and others on nightlife premises

    Participating establishments could administer program-supplied naloxone or other approved opioid antagonists to people on site experiencing an opioid emergency.

  • New York State Department of Health

    The department would administer the program, publish participating establishments online, set operating rules, oversee compliance and report annually on doses distributed and administered.

Headline styles

Free Narcan for Nightlife

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Leroy Comrie

Senator · Senate District 14

Chair, Corporations, Authorities And Commissions

History

  1. Approval memo.72
  2. Signed chap.778
  3. Delivered to governor
  4. Returned to senate
  5. Passed assembly
  6. Ordered to third reading rules cal.709
  7. Substituted for A9697A
  8. Referred to health
  9. Delivered to assembly
  10. Passed senateVote 60–1
  11. Ordered to third reading cal.1447
  12. Reported and committed to rules
Show 4 earlier actions
  1. Reported and committed to finance
  2. Print number 8633a
  3. Amend and recommit to alcoholism and substance abuse
  4. Referred to alcoholism and substance abuse

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A9697Assembly

Free Narcan for Nightlife

Assembly Floor Calendar · Sponsor Judy Griffin

Impact 7 · Significant0% to pass

Full text

3 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

8633--A

IN SENATE

March 23, 2022

Introduced by Sens. COMRIE, GAUGHRAN, HOYLMAN, SALAZAR, SEPULVEDA -read twice and ordered printed, and when printed to be committed to the Committee on Alcoholism and Substance Abuse -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee

AN ACT to amend the public health law, in relation to establishing the nightlife opioid antagonist program

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. The public health law is amended by adding a new section 3309-b to read as follows:

§ 3309-b. Nightlife opioid antagonist program. 1. Definitions. As used in this section the following terms shall have the following meanings:

a. "Nightlife establishment" means an establishment that is open to the public for entertainment or leisure, serves alcohol or where alcohol is consumed on the premises, and conducts a large volume of business at night. Such term includes, but is not limited to, bars, entertainment venues, clubs and restaurants.

b. "Opioid antagonist" means a drug approved by the Food and Drug Administration that, when administered, negates or neutralizes in whole or in part the pharmacological effects of an opioid in the body. "Opioid antagonist" shall be limited to naloxone and other medications approved by the department for such purpose.

2. Program. The commissioner shall establish a program whereby a nightlife establishment may apply to receive an opioid antagonist, free of charge, to be administered to patrons, staff or individuals on premises of such establishment. Such program shall be operated in compliance with existing laws, rules and regulations relating to the distribution of an opioid antagonist. The department shall publish on its website a list of each participating establishment.

3. Eligibility. a. To be eligible to participate in the program created by this section, a nightlife establishment shall agree to comply with the requirements of this section and any rule or regulation promulgated pursuant to this section.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD15059-02-2

b. A nightlife establishment applying to participate in the program shall submit an application by mail or online through the department's website on a form promulgated by the commissioner.

4. Approval. Except as otherwise provided by law, the commissioner shall approve an application submitted pursuant to subdivision three of this section if the application satisfies all of the requirements of this section. If an application does not satisfy the requirements of this section, the commissioner shall notify the applicant in writing the deficiencies in the application without prejudice to reapply.

5. Fees. The commissioner shall not charge a fee to a participating establishment for receipt of an opioid antagonist or participation in the program.

6. Terms and conditions of participation. a. Each participating establishment is permitted to request to receive a maximum of ten doses of an opioid antagonist at one time. After a report has been made to the department pursuant to paragraph b of this subdivision, such establishment may apply to receive additional doses of an opioid antagonist up to the maximum of ten such doses per establishment.

b. A participating establishment shall report to the department each time:

(i) A dose of an opioid antagonist received pursuant to the program is used on a person experiencing an emergency; or

(ii) A dose of an opioid antagonist received pursuant to the program has been accidentally or inappropriately discharged or may otherwise no longer be administered effectively.

(iii) A majority of the doses issued to the establishment have expired.

c. An opioid antagonist received pursuant to the program shall only be used by a participating establishment at the location of such establishment in the state.

d. The commissioner shall promulgate rules and regulations that shall govern the use of opioid antagonists by participating establishments. Such rules and regulations shall include, but shall not be limited to, best practices, standards and policies that participating establishments shall meet in connection with:

(i) The conduct of participating establishments;

(ii) The administration of an opioid antagonist;

(iii) Advertisement of the program, including the dangers of opioid use and the effects of the administration of an opioid antagonist;

(iv) The privacy of information for participating establishment staff and individuals who receive a dose of an opioid antagonist;

(v) Communication between participating establishments and their patrons regarding the program;

(vi) Communication between the department and participating establishments; and

(vii) Any other best practices, standards or policies that the commissioner determines would further the purposes of this section.

e. A participating establishment shall comply with all applicable federal, state and local laws, rules and regulations, including the requirements of this section and the rules and regulations promulgated thereunder, and shall keep records of opioid antagonist administration on site and available for inspection upon request of an employee or an agent of the department.

7. Supervision of program. a. Where a participating establishment violates any federal, state or local law, rule or regulation or the requirements of this section, the commissioner may suspend such establishment's participation in the program, upon due notice and opportunity to be heard.

b. The commissioner may immediately suspend a participating establishment's participation in the program without a prior hearing where the commissioner determines that such establishment's continued participation poses a serious danger to public health, safety or welfare, provided that after such suspension an opportunity for hearing shall be provided on an expedited basis.

c. Suspension from the program under this section shall be in addition to any other penalties provided by applicable laws, rules or regulations.

d. A participating establishment may participate in the program after a suspension has been imposed pursuant to this section if such establishment has:

(i) cured all violations;

(ii) demonstrated full compliance with all applicable federal, state and local laws, rules and regulations; and

(iii) applied for reinstatement and such reinstatement has been granted by the commissioner.

e. Where a participating establishment has had its participation in the program suspended two times or more, and the participating establishment subsequently violates any applicable law, rule or regulation or the requirements of this section, the commissioner may suspend its participation in the program indefinitely.

8. Training. The department shall offer to staff of participating establishments resources and training on overdose prevention and administration of an opioid antagonist.

9. Disclaimer of liability. The state shall not be liable for any use or administration of an opioid antagonist by a participating establishment. The state does not warranty the completeness, accuracy, content or fitness for any particular purpose of any information made available by a participating establishment regarding the program, nor are any such warranties to be implied or inferred with respect to the information furnished therein. The state shall not be liable for any deficiencies in the completeness, accuracy, content or fitness for any particular purpose or use of information provided by any third party and made available by a participating establishment regarding the program.

10. Report. No later than March first, two thousand twenty-three, and annually thereafter, the department shall submit a report to the governor, the temporary president of the senate, the minority leader of the senate, the speaker of the assembly, and the minority leader of the assembly on the administration of opioid antagonists pursuant to the program. The report shall include, but need not be limited to, the following information for the previous calendar year:

a. The total number of doses of an opioid antagonist provided to participating establishments;

b. The total number of doses of an opioid antagonist received by each participating establishment;

c. The total number of times an opioid antagonist was administered by a participating establishment, disaggregated by establishment; and

d. The total number of times an opioid antagonist was inappropriately administered by a participating establishment, including the reasons for such improper administration, disaggregated by establishment.

§ 2. This act shall take effect on the one hundred twentieth day after it shall have become a law.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the public health law, in relation to establishing the nightlife opioid antagonist program

Purpose

To establish the voluntary night-lite opioid antagonist program and prevent needless opioid overdose deaths in night clubs.

Summary of provisions

Section 1 creates a new section 3309-b to the public health law, requir- ing the Commissioner of the Department of Health to establish a night- life opioid antagonist program, and establishes definitions to include "nightlife establishment" as inclusive of businesses such as bars, clubs, and restaurants, and defines "opioid antagonist" to include narcan, naloxone, and other FDA-recognized opioid overdose treatments found by medical professionals to reduce or prevent death.

Read the full memo (938 words)

Section 2 creates the program whereby a nightlife establishment can receive an opioid antagonist in line with existing law, free of charge, and directs the health department to publish participating establish- ments online for public view.

Section 3 establishes eligibility criteria to include compliance with requirements c)f this section, and that applications shall be submitted either by mail or online.

Section 4 sets approval via satisfying the requests stated above. It also requires that an application that is initially declined by the commissioner result in notification to the applicant as to their defi- ciencies in writing to encourage reapplication without prejudice.

Section 5 makes clear that there will be no fee for participating estab- lishments.

Section 6 states participating establishments would receive a maximum of 10 doses and report to the department when doses were discharged, wheth- er because of an actual emergency as stated by the purpose of the program, an accidental discharge, or if a dose is no longer effective. Additionally, the antagonist is non-transferrable and must be used at the participant establishment that applied to the program. The commis- sioner will set forth rules and regulation as needed.

Section 7 grants the department commissioner and power to withdraw participants from the program in the event their participation poses a danger to public. health,or welfare, provided that after such suspension an opportunity for hearing shall be provided on an expedited basis. An establishment whose participation has been suspended may reap- ply with proof that disqualifying issues have been remedied.

Section 8 requires the department offer the staff of participant estab- lishments necessary resources and training on overdose prevention and the administration of opioid antagonists provided by this program. It is

stated that only staff who have received such training are authorized to administer the on-site antagonist.

Section 9 makes clear that the state has No liability associated with the administration of the program at these voluntarily participating establishments.

Section 10 provides that every March 1" beginning 2023 from the effec- tive date of this hill's passage that the department will provide infor- mation on the administration of the program to the office of the gover- nor and leaders of both houses of the state legislature. Such a report shall .include the total number of doses provided to each establishment, the number of times a dose was discharged, and the number of times a dose was improperly discharged.

Section 11 establishes an effective date 120 days after passage.

Justification

This bill will authorize training and put life-saving treatment into the hands of nightlife establishment employees, similar to AEDs. Nightlife establishments are one of many everyday contexts in which statistics tell us opioids are consumed at a higher frequency. This program seeks to bring overdose prevention to as many responsibly-minded bars and nightclubs as possible - especially as they recognize that beyond the intentional consumption of opioids themselves, people who consume other drugs, including cocaine, crack, heroin, methamphetamine, ketamine, and pills from various sources are potentially exposed to tentanyl. Anyone who uses drugs that may contain fentanyl, even occasionally, is at risk of a fatal overdose.

An opioid antagonist is a life-saving treatment that rapidly reverses an opioid overdose. When administered to someone in need, it attaches to opioid receptors in their body and reverses and blocks the effects of other opioids. Narcan, naloxone, and similar FDA-approved opioid antag- onists have been proven to restore normal breathing to a person if their lung and heart function has dramatically slowed or stopped due to an opioid overdose; it can often make the difference between life and death.

In addition to providing opioid antagonist training for nightlife work- ers and making these treatments more readily available to people across the state, this program will supplement existing educational and aware- ness programs to reduce senseless overdose deaths and curb the consump- tion of drugs by New York residents.

In 2018, the New York City department of Health and mental Hygiene (DOHMH) collaborated with the Brooklyn Ailed Bars & Restaurants (BABAR) to reach bar and nightclub owners as well ,s staff to begin an overd -e - prevention pilot program. This intervention was part of the overall comprehensive plan by the City of New York to address the recent opioid crisis in both its own jurisdiction and across the state, given its location as a central gathering place for recreation and entertainment. After showing initial success, the program was expanded in 2019.

This bill finds parity with an existing bill of the New York City Coun- cil to extend the benefits of that program. After this established success and with an understanding of the risks of opioid overdose on too many New Yorkers, this bill aims to offer a similar program to estab- lishments beyond the City of New York.

Prior legislative history

New bill.

Fiscal implications

To be determined.

Effective date

This bill shall take effect on the one hundred twentieth day after it becomes law.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.